A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
about
The clinical potential of exhaled breath analysis for diabetes mellitusEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesA highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detectionThe scent of disease: volatile organic compounds of the human body related to disease and disorderUrinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancerPhotoacoustic Spectroscopy for the Determination of Lung Cancer Biomarkers-A Preliminary Investigation.Breath tests in respiratory and critical care medicine: from research to practice in current perspectivesApplication of femtosecond laser mass spectrometry to the analysis of volatile organic compounds.Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.Noninvasive detection of lung cancer by analysis of exhaled breath.Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibromaExhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation.Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.Product ion distributions for the reactions of NO(+) with some physiologically significant aldehydes obtained using a SRI-TOF-MS instrument.Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.Unique volatolomic signatures of TP53 and KRAS in lung cells.Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice.Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles.The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study.Metabolomics-based methods for early disease diagnosticsIdentification of volatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au-Ag alloy coated MWCNTs.Blood volatile compounds as biomarkers for colorectal cancer.Early detection and screening of lung cancer.Lung cancer biomarkers in exhaled breath.In vivo solid-phase microextraction in metabolomics: opportunities for the direct investigation of biological systems.Molecular biomarkers for future screening of lung cancer.Exhaled breath analysis for lung cancer.Re-exploring the high-throughput potential of microextraction techniques, SPME and MEPS, as powerful strategies for medical diagnostic purposes. Innovative approaches, recent applications and future trends.Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease.Classification of lung cancer histology by gold nanoparticle sensors.Hybrid volatolomics and disease detection.Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose.Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's "chemical odor fingerprint".Detection and identification of cancers by the electronic nose.Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.A novel device based on a fluorescent cross-responsive sensor array for detecting lung cancer related volatile organic compounds.Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?A preliminary analysis of volatile metabolites of human induced pluripotent stem cells along the in vitro differentiation
P2860
Q27002406-CE7BEA2B-1CD8-4DCE-A961-70C4DCF1C18AQ27023830-2F944BEB-B16E-4B44-9FBB-8AA601B92ECCQ27313319-6A94E2F0-EA9C-40B3-89BD-A3E0E3861364Q28243639-05E69FF6-B11C-4DC6-B24C-DAEFBBFD9159Q28472660-21DF6D59-0C02-48F0-840C-75572AC15672Q30363643-AFF0C2F3-3D62-4694-B0A5-0FE4773E98AFQ30448113-C98EC118-EDBB-478B-9F50-5FBACC42BF7AQ30979718-3735C211-F8A8-497A-A3F9-0CE78F9E5805Q33435548-05A34A4E-53FA-42D3-9222-F14BFE6DB90AQ33507435-3A453FC4-FD6C-49B9-B7AA-7AC0B2DFF6D1Q33781116-5BAA0789-C369-443F-BB05-0D489B4041CDQ34648188-307E4FE9-725F-42EC-819C-CB16E017B848Q34683513-52279FDA-D035-4CE3-838E-EB2D4C555347Q35222140-58449CDE-46CC-4163-AA9D-63B0D4E5B499Q35653903-98833539-C555-4F1D-AB7D-27CD55AE4B65Q35678408-84F825E5-920A-4F97-8FDC-61A67E4C9F8BQ35854350-D3447CC2-849A-49F5-BD53-D72E4BC6CE27Q35876638-41DB610C-2D7C-4342-9263-EB9A2099ADA1Q36011615-13AA7001-900D-4408-95F8-1A830728D25CQ36152438-37508E15-796E-442D-9BAF-21F6361F8E18Q37161693-7A0635FB-ED44-4B59-AAB5-4016C08345CBQ37266489-5041825A-67AF-40D8-A31B-500BCC63B900Q37511119-6B9002B2-90DC-45CB-BD9A-CAD2459BF709Q37591469-E5272046-C141-46BC-A549-F8F1E0C3B2E2Q37789035-EC49E1CE-D358-40B7-9BA1-5E136D29CE76Q37853184-6A617F1C-4636-4432-9452-473AA219F8ACQ37879073-48BB2B08-A901-4ABC-AD6D-475F135DDE91Q38124776-CAF03C4A-4AA0-439C-883E-0B1D2715AFBDQ38155853-16F29D89-50B3-4C6B-8154-B6C87FA7E2BBQ38179931-98651CFB-F9EC-4500-A815-A7131EAFE41DQ38182688-B1653467-22E6-4F4D-B912-B018E4037B9EQ38286916-018C093E-308A-4389-AF06-58603A647988Q38559382-3B209B77-164D-4A53-BF90-953BD29ACED9Q39266919-B9AB895A-2C8C-4FF3-8E21-9B78807A3F43Q39367135-09A1439E-9F1D-4EB5-9EA5-297F2ADC39CAQ39453568-C2E0A2D3-C829-4268-92B7-239FCDC3ADDAQ39893495-B6EAB239-CB06-4DCD-B0DB-FF2A53A96948Q41335164-DE86C3E9-0965-477C-93E4-4ACAE85DE4E3Q41593380-4B606BA4-02CA-4799-B261-2F10C5AEEAB1Q42267058-6238346D-B5B0-4F2C-ABB0-3FF0BC69112D
P2860
A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A study of the volatile organi ...... in vitro for breath diagnosis.
@en
A study of the volatile organi ...... in vitro for breath diagnosis.
@nl
type
label
A study of the volatile organi ...... in vitro for breath diagnosis.
@en
A study of the volatile organi ...... in vitro for breath diagnosis.
@nl
prefLabel
A study of the volatile organi ...... in vitro for breath diagnosis.
@en
A study of the volatile organi ...... in vitro for breath diagnosis.
@nl
P2093
P356
P1433
P1476
A study of the volatile organi ...... in vitro for breath diagnosis.
@en
P2093
Enguo Chen
Fengjuan Xu
Kejing Ying
Weimin Zhang
Yuefeng Pan
P304
P356
10.1002/CNCR.22844
P407
P577
2007-08-01T00:00:00Z